According to a market report by Lucintel, the future of the digital PCR (dPCR) and real-time PCR (qPCR) market looks promising with opportunities in hospitals & diagnostic centers, pharmaceutical & biotechnology companies, clinical research organizations (CROs), and forensic laboratories. The global digital PCR (dPCR) and real-time PCR (qPCR) market is expected to reach an estimated $9.9 billion by 2028 with a CAGR of 7.2% from 2023 to 2028. The major drivers for this market are increasing use of biomarker profiling for disease diagnostics, growing cases of genetic disorders, and ongoing technological advancements in PCR technologies.
In this market reagents and consumables, instruments, and software and services are the major product & service segments. Lucintel forecasts that reagents and consumables will remain the largest product & service segment over the forecast period due to growing requirement for earlier detection of diseases, increasing cases of chronic conditions, and rising number of significant companies manufacturing digital PCR consumables and reagents.
Within this market, hospitals & diagnostic centers will remain the largest end use industry segment over the forecast period due to and growing public awareness of the benefits of dPCR in disease diagnosis and increasing number of dPCR product launches for diagnostic applications.
North America will remain the largest region during the forecast period due to increasing availability of research and development funding for genomic research, presence of favorable regulations, and high disease prevalence in the region.
Abbott Laboratories, Qiagen, Bio-Rad Laboratories, Agilent Technologies, Thermo Fisher Scientific, GE Healthcare, biomérieux, Roche Ltd, and Fluidigm Corporation are the major suppliers in the global digital PCR (dPCR) and real-time PCR (qPCR) market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global digital PCR (dPCR) and real-time PCR (qPCR) market by product & service, application, end use industry, and region. Lucintel has compiled a comprehensive research report titled “Growth Opportunities in the Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global digital PCR (dPCR) and real-time PCR (qPCR) market by product & service, application, end use industry, and region, as follows:
Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product & Service [Value ($B) Shipment Analysis from 2017 to 2028]:
Reagents and Consumables
Instruments
Software and Services
Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:
Clinical Applications
Research Applications
Forensic Applications
Digital PCR (dPCR) and Real-time PCR (qPCR) Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:
Hospitals & Diagnostic Centers
Pharmaceutical & Biotechnology Companies
Clinical Research Organizations (CROs)
Forensic Laboratories
Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
North America
Europe
Asia Pacific
The Rest of the World
This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.
About Lucintel Lucintel, the premier global
Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis,
Growth Consulting, M&A, and
Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
This report answers the following 11 key questions: Q.1. What are some of the most promising, high-growth opportunities for the global digital PCR (dPCR) and real-time PCR (qPCR) market by product & service (reagents and consumables, instruments, and software and services), application (clinical applications, research applications, and forensic applications), end use industry (hospitals & diagnostic centers, pharmaceutical & biotechnology companies, clinical research organizations (CROs), and forensic laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity did occur in the last five years and how did they impact the industry?